Positron Emission Tomography Applications in Prostate Cancer Detection
Summary
Positron emission tomography (PET) has emerged as a pivotal imaging modality in the detection, staging and management of prostate cancer. By administering a radiotracer that selectively binds to targets expressed by malignant cells, PET can reveal occult disease sites that elude conventional imaging. In prostate cancer, the most widely adopted radiotracers target the prostate-specific membrane antigen (PSMA), a transmembrane protein overexpressed on malignant prostate epithelium. PSMA-targeted PET enables high-contrast visualisation of primary tumours, lymph node involvement and distant metastases, often at very low levels of circulating prostate-specific antigen (PSA). Beyond diagnosis, PET contributes to treatment planning by delineating extent of disease, guiding focal therapies and monitoring response to systemic treatment. Advances in tracer chemistry, hybrid imaging with CT or MRI, and quantitative measures such as the standardised uptake value (SUV) have refined accuracy and reproducibility. Emerging protocols integrate PET findings with artificial intelligence and multiparametric data to deliver precision management, minimise unnecessary biopsies and personalise the therapeutic pathway. Taken together, PET represents a transformative tool for improving patient outcomes through earlier and more accurate detection of prostate cancer spread.
Research from Nature Portfolio
No recent Nature Portfolio content available.
Positron Emission Tomography Applications in Prostate Cancer Detection publication trend
The graph below shows the total number of articles in positron emission tomography applications in prostate cancer detection across all publications each year (not limited to Nature Index journals).
Technical terms
Positron Emission Tomography (PET): A functional imaging technique that detects pairs of gamma rays emitted indirectly by a positron-emitting radiotracer to map metabolic or molecular activity in the body.
Prostate-Specific Membrane Antigen (PSMA): A cell-surface protein highly expressed on prostate cancer cells, used as a target for radiolabelled imaging and therapeutic agents.
Radiotracer: A radioactive compound administered to a patient that binds selectively to a biological target, enabling its visualisation by PET.
Standardised Uptake Value (SUV): A semiquantitative metric representing tracer concentration in a region of interest, corrected for injected dose and patient body weight, used to compare lesion activity.
References
- Radiotheranostics in oncology: Making precision medicine possible. CA A Cancer Journal for Clinicians (2023).
- Molecular and functional imaging in cancer-targeted therapy: current applications and future directions. Signal Transduction and Targeted Therapy (2023).
About these summaries
This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.